Stefan Barta, MD

Stefan Barta, MD, is an associate professor of clinical medicine and director of the T-cell lymphoma program, University of Pennsylvania Department of Medicine.

Articles by Stefan Barta, MD

Breaking Down the Barriers to Effective T-Cell Lymphoma Treatment

ByStefan Barta, MD

September 4th 2024

Stefan Barta, MD, discusses the heterogeneity of T-cell lymphoma, highlighting that a one-size-fits-all approach is ineffective and emphasizing the need for tailored treatment approaches.

Latest Updated Articles

Breaking Down the Barriers to Effective T-Cell Lymphoma Treatment
Published: September 4th 2024 | Updated:

Stefan Barta, MD

Articles by Stefan Barta, MD

Breaking Down the Barriers to Effective T-Cell Lymphoma Treatment

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update